Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042)

Expanded access is no longer available for this treatment.

Study NCT00419367 Information provided by Merck

First Received: January 5, 2007 Last Updated: February 9, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	Expanded access is no longer available for this treatment.
Estimated Study Completion Date:	May 2011
Estimated Primary Completion Date:	May 2011 (Final data collection date for primary outcome measure)